Tersavid (RO 4-1634), an amine oxidase inhibitor, for the treatment of angina pectoris. Up to 15 months follow-up study.
D000588:Amines; D000787:Angina Pectoris / Q000628:therapy*; D005500:Follow-Up Studies; D006834:Hydrazines / Q000628:therapy*; D008996:Monoamine Oxidase Inhibitors; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D011422:Propionates
D000588:Amines; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D011422:Propionates; D010088:Oxidoreductases; C008928:pivalylbenzhydrazine
ANGINA PECTORIS/therapy; HYDRAZINES/therapy; OXIDASES/antagonists